Depression News

Forty-eight percent of American public health personnel reported at least one mental health issue, a small drop from 2021, according to survey responses published in MMWR.

A recently published survey revealed that nearly two-thirds of Americans believe people dealing with mental health conditions are treated differently.

The FDA has provided guidance to biopharmaceutical company Alzamend Neuro Inc. regarding its development of an oral therapeutic to treat a range of psychological disorders.

The FDA has approved Neuronetics’ NeuroStar Advanced Therapy for Mental Health, a transcranial magnetic stimulation system for treatment of anxiety symptoms in adults with major depressive disorder, the company announced in a press release.

Eight of 10 workers in the United States said mental health support from employers is a top consideration during future job searches, according to a new survey from the American Psychological Association.

The COVID-19 pandemic negatively impacted caregivers and non-caregivers alike, with evidence of increased alcohol consumption and depressive symptoms along with significant sleep disturbances, according to a study published in Alcohol.

Avant Institute received a grant from Davos Alzheimer’s Collaborative to perform cognitive screening at pharmacies in rural and underserved communities nationwide, according to a press release.

Black, Hispanic and Asian American-Pacific Islander individuals feel less comfortable engaging in mental health discussions in the workplace compared with their white colleagues, new research shows.

The United States on Saturday, July 16, will transition the 10-digit National Suicide Prevention Lifeline to 988, an easy-to-remember number for 24/7 crisis care.

A group of national physician organizations has issued a call to action to integrate behavioral health services into primary care settings.